pubmed-article:17308732 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17308732 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
pubmed-article:17308732 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
pubmed-article:17308732 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
pubmed-article:17308732 | lifeskim:mentions | umls-concept:C0243161 | lld:lifeskim |
pubmed-article:17308732 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
pubmed-article:17308732 | lifeskim:mentions | umls-concept:C1963724 | lld:lifeskim |
pubmed-article:17308732 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:17308732 | pubmed:dateCreated | 2007-2-19 | lld:pubmed |
pubmed-article:17308732 | pubmed:abstractText | To estimate the probability of reaching the criteria for starting highly active antiretroviral therapy (HAART) in a prospective cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire. | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:language | eng | lld:pubmed |
pubmed-article:17308732 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17308732 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17308732 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17308732 | pubmed:month | Feb | lld:pubmed |
pubmed-article:17308732 | pubmed:issn | 0042-9686 | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:SalamonRogerR | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:MingaAlbertA | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:BonardDominiq... | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:DabisFrançois... | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:AnglaretXavie... | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:DanelChristin... | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:DohounLambert... | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:AboYaoY | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:CoulibalyAliA | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:DuvignacJulie... | lld:pubmed |
pubmed-article:17308732 | pubmed:author | pubmed-author:ANRS 1220... | lld:pubmed |
pubmed-article:17308732 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17308732 | pubmed:volume | 85 | lld:pubmed |
pubmed-article:17308732 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17308732 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17308732 | pubmed:pagination | 116-23 | lld:pubmed |
pubmed-article:17308732 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:meshHeading | pubmed-meshheading:17308732... | lld:pubmed |
pubmed-article:17308732 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17308732 | pubmed:articleTitle | Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire. | lld:pubmed |
pubmed-article:17308732 | pubmed:affiliation | Programme PAC-CI, Abidjan, Côte d'Ivoire. minga.albert@caramail.com | lld:pubmed |
pubmed-article:17308732 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17308732 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17308732 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17308732 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17308732 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17308732 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17308732 | lld:pubmed |